World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03276325
Date of registration: 06/09/2017
Prospective Registration: Yes
Primary sponsor: Mansoura University
Public title: Epidural Steroids With Intrathecal Nalbuphine for Lower Abdominal Oncologic Surgery
Scientific title: Epidural Steroids Combined With Intrathecal Nalbuphine: Analgesic and Side Effects Concept in Lower Abdominal Surgical Oncology Procedures
Date of first enrolment: September 15, 2017
Target sample size: 70
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03276325
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Other. Masking: Double (Care Provider, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Egypt
Contacts
Name:     Mohamed A Ghanem, MD
Address: 
Telephone:
Email:
Affiliation:  Assistant Professor of Anesthesia and Surgical Intensive Care
Key inclusion & exclusion criteria

Inclusion Criteria:

- American Society of Anesthesiologists physical class I or II.

- Undergoing laparotomy

- Undergoing oophorectomy

- Undergoing hysterectomy

- Undergoing rectal mass excision

Exclusion Criteria:

- Patient refusal.

- Hypersensitivity to amide local anesthetics.

- General contraindications to spinal anesthesia.

- Cardiac diseases.

- Hepatic failure.

- Renal failure.

- Respiratory failure.

- Communication barriers.



Age minimum: 18 Years
Age maximum: 60 Years
Gender: All
Health Condition(s) or Problem(s) studied
Lower Abdominal Oncologic Surgery
Intervention(s)
Drug: Placebo-nalbuphine
Drug: Dexamethasone-nalbuphine
Primary Outcome(s)
Pain score [Time Frame: For 24 hours after surgery]
Secondary Outcome(s)
Motor recovery [Time Frame: For 5 hours after induction of anaesthesia]
Nausea and vomiting [Time Frame: For 24 hours after surgery]
Sensory recovery [Time Frame: For 5 hours after induction of anaesthesia]
Cumulative use of rescue intravenous ketorolac [Time Frame: for 24 hrs after surgery]
Postoperative heart rate changes [Time Frame: For 24 hours after surgery]
Cumulative use of rescue intravenous nalbuphine [Time Frame: For 24 hours after surgery]
Cumulative use of antiemetic [Time Frame: for 24 hrs after surgery]
First analgesic request [Time Frame: For 12 hours after induction of anaesthesia]
Intraoperative heart rate changes [Time Frame: For 3 hours after induction of anaesthesia]
Intraoperative mean arterial blood pressure changes [Time Frame: For 3 hours after induction of anaesthesia]
Postoperative mean arterial blood pressure changes [Time Frame: For 24 hours after surgery]
Secondary ID(s)
R/17.04.127
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history